Search research articles
Contact Us
Filters
Showing results (101-110 of 1,050) with videos related to
Page
of 105
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 2, 2021
Reply
David Simon, Filippo Fagni, Koray Tascilar, et al.
Current Opinion in Rheumatology
|
November 4, 2025
CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation
Panagiotis Garantziotis, Janina Auth, Georg Schett, et al.
Bone
|
June 10, 2022
Rheumatoid arthritis and osteoimmunology: The adverse impact of a deregulated immune system on bone metabolism
Darja Andreev, Katerina Kachler, Georg Schett, et al.
The New England Journal of Medicine
|
November 17, 2021
Reframing Immune-Mediated Inflammatory Diseases. Reply
Georg Schett, Iain B McInnes, Markus F Neurath
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 18, 2023
Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach
Filippo Fagni, Francesca Motta, Georg Schett, et al.
Rheumatology (Oxford, England)
|
June 19, 2019
Calcium pyrophosphate deposition disease induced inflammatory back pain
Arnd Kleyer, Johannes Knitza, Georg Schett, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 2, 2017
Reply to: Osteoporosis: An Independent Determinant of Bone Erosions in Rheumatoid Arthritis?
David Simon, Christoph Simon, Arnd Kleyer, et al.
Arthritis and Rheumatism
|
January 31, 2009
The emergence of antineutrophil cytoplasmic antibodies may precede the clinical onset of Churg-Strauss syndrome
Jochen Zwerina, Roland Axmann, Bernhard Manger, et al.
Annals of the Rheumatic Diseases
|
May 22, 2007
Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?
Georg Schett, Robert Landewé, Désirée van der Heijde
Innere Medizin (Heidelberg, Germany)
|
June 30, 2025
[CAR T cells in non-malignant diseases]
Fabian Müller, Melanie Hagen, Georg Schett, et al.
Page
of 105
Search research articles
Search
Showing results (101-110 of 1,050) with videos related to
Sort By:
Page
of 105
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 2, 2021
Reply
David Simon, Filippo Fagni, Koray Tascilar, et al.
Current Opinion in Rheumatology
|
November 4, 2025
CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation
Panagiotis Garantziotis, Janina Auth, Georg Schett, et al.
Bone
|
June 10, 2022
Rheumatoid arthritis and osteoimmunology: The adverse impact of a deregulated immune system on bone metabolism
Darja Andreev, Katerina Kachler, Georg Schett, et al.
The New England Journal of Medicine
|
November 17, 2021
Reframing Immune-Mediated Inflammatory Diseases. Reply
Georg Schett, Iain B McInnes, Markus F Neurath
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 18, 2023
Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach
Filippo Fagni, Francesca Motta, Georg Schett, et al.
Rheumatology (Oxford, England)
|
June 19, 2019
Calcium pyrophosphate deposition disease induced inflammatory back pain
Arnd Kleyer, Johannes Knitza, Georg Schett, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 2, 2017
Reply to: Osteoporosis: An Independent Determinant of Bone Erosions in Rheumatoid Arthritis?
David Simon, Christoph Simon, Arnd Kleyer, et al.
Arthritis and Rheumatism
|
January 31, 2009
The emergence of antineutrophil cytoplasmic antibodies may precede the clinical onset of Churg-Strauss syndrome
Jochen Zwerina, Roland Axmann, Bernhard Manger, et al.
Annals of the Rheumatic Diseases
|
May 22, 2007
Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?
Georg Schett, Robert Landewé, Désirée van der Heijde
Innere Medizin (Heidelberg, Germany)
|
June 30, 2025
[CAR T cells in non-malignant diseases]
Fabian Müller, Melanie Hagen, Georg Schett, et al.
Page
of 105